FDA
-
-
-
-
-
-
-
Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting
-
-
-
-
-
-
-
Phexxi -- A Non‑Hormonal Birth Control Brand -- Goes Viral with Microfeminism on TikTok, Featured by BuzzFeed and Scary Mommy
-
-
-
-
-
-
-
Evofem Reports Fourth Consecutive Year of Net Sales Growth
-
-
-
-
-
-
-
Appili Therapeutics Reports Financial and Operational Results for Third Quarter of Fiscal Year 2025
-
-
-
-
-
-
-
Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
-
-
-
-
-
-
-
Aditxt, Inc (ADTX) Issues Shareholder Update and 2024 Year-End Plan
-
-
-
-
-
-
-
Evofem Biosciences Addresses the Impact of GLP-1 Medications on Oral Contraceptive Absorption and Introduces Phexxi as a Non-Oral Solution
-
322,943 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

